Physician
Chu, Andrew
Chu, Andrew was paid $186K by Medicaid between Apr 2019 and Dec 2024, across 59 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 19% of everything it billed.
33Billing provider infoCHU, ANDREW
SAINT LOUIS, MO 63136
SAINT LOUIS, MO 63136
33aNPI1093006181assigned 04/25/2011
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$186K
24GClaims34,189
24DCodes billed59
24AFirst – last monthApr 2019 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Missouri
Rank by total paid#10 of 103
Median peer was paid$15K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 12 | $306.20 | |
| 2021 | 1,446 | $12K | |
| 2022 | 1,466 | $10K | |
| 2023 | 5,367 | $32K | |
| 2024incomplete | 25,898 | $132K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 19% | 1,489 | 1,289 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12% | 8,093 | 5,202 | $23K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 11% | 607 | 583 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.3% | 1,014 | 956 | $8K |
| 80053 | Comprehensive metabolic panel | 3.6% | 1,323 | 949 | $7K |
| 83735 | 3.5% | 1,920 | 764 | $7K | |
| 83880 | 3.4% | 471 | 324 | $6K | |
| 84484 | 3.2% | 961 | 726 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.7% | 130 | 109 | $5K |
| 82803 | 2.3% | 495 | 356 | $4K | |
| 80061 | Lipid panel | 2.2% | 925 | 864 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.1% | 920 | 453 | $4K |
47 more codes
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 1.9% | 246 | $4K |
| 83605 | 1.9% | 714 | $4K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 1.7% | 193 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 165 | $3K |
| 85027 | 1.6% | 1,060 | $3K | |
| 83690 | 1.6% | 892 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 135 | $3K |
| 84702 | 1.4% | 516 | $3K | |
| 82962 | 1.4% | 1,204 | $3K | |
| 81025 | 1.3% | 838 | $2K | |
| 81001 | 1.0% | 1,342 | $2K | |
| 86901 | <1% | 934 | $2K | |
| 86850 | <1% | 568 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 525 | $2K |
| 85610 | <1% | 826 | $2K | |
| 86900 | <1% | 947 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 156 | $1K |
| 82607 | <1% | 206 | $1K | |
| 88307 | <1% | 12 | $971.64 | |
| 83550 | <1% | 220 | $896.88 | |
| 85379 | <1% | 234 | $873.75 | |
| 86592 | <1% | 412 | $818.00 | |
| 85730 | <1% | 247 | $813.16 | |
| 86704 | <1% | 137 | $800.81 | |
| 87340 | <1% | 156 | $786.76 | |
| 86140 | <1% | 330 | $770.52 | |
| 81003 | <1% | 711 | $759.73 | |
| 83540 | <1% | 223 | $677.45 | |
| 87070 | <1% | 167 | $590.02 | |
| 80081 | <1% | 20 | $587.32 | |
| 84439 | <1% | 142 | $565.87 | |
| 82728 | <1% | 125 | $534.40 | |
| 82746 | <1% | 92 | $491.51 | |
| 82248 | <1% | 183 | $410.85 | |
| 80069 | <1% | 98 | $409.83 | |
| 87205 | <1% | 197 | $394.10 | |
| 82570 | <1% | 150 | $331.59 | |
| 86880 | <1% | 101 | $288.10 | |
| 83516 | <1% | 64 | $271.28 | |
| 85652 | <1% | 196 | $255.65 | |
| 88342 | <1% | 12 | $254.53 | |
| 84550 | <1% | 71 | $146.34 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 12 | $98.56 |
| 82043 | <1% | 23 | $40.24 | |
| 82950 | <1% | 12 | $25.61 | |
| 84132 | <1% | 12 | $24.75 | |
| 84156 | <1% | 15 | $18.57 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.